ArticleMolecular oncology2020

TR1801-ADC: a highly potent cMet antibody-drug conjugate with high activity in patient-derived xenograft models of solid tumors.

Marco Gymnopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.